Anaplastic thyroid carcinoma: Treatment in the age of molecular targeted therapy

Research output: Contribution to journalReview articlepeer-review

67 Scopus citations

Abstract

Anaplastic thyroid carcinoma is one of the most aggressive and deadly cancers in humans and accounts for one to two cases per million persons annually. The rarity of this malignancy and the rapidity bywhich it grows has been amajor barrier to progress in finding effective therapies. Thus, the treatment that is the current standard of care for these patients is largely palliative, andfeware cured;however,novel therapies andapproaches are being studied in patients with anaplastic thyroid carcinoma and are delineated herein.

Original languageEnglish (US)
Pages (from-to)511-518
Number of pages8
JournalJournal of oncology practice
Volume12
Issue number6
DOIs
StatePublished - Jun 2016

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)
  • Health Policy

Fingerprint

Dive into the research topics of 'Anaplastic thyroid carcinoma: Treatment in the age of molecular targeted therapy'. Together they form a unique fingerprint.

Cite this